Oruka Therapeutics, Inc.
ORKA NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 10, 2026
ET
EPS Est.
-0.51
EPS Actual
-0.55
Revenue Est.
--
Revenue Actual
--
Next Earnings Report Date unconfirmed
Date
Nov 11, 2026 · Wed
ET Nov 11, 2026 · Wed
Time
11/11 11:00-14:30
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
-0.60
Revenue Est.
--
Company Overview
Oruka Therapeutics, Inc. (ticker ORKA) is listed on NASDAQ with a market cap of about $5.1B. Its next earnings report (FY2026 Q3) is expected on Nov 11, 2026 (ET), Pre-market (date pending company confirmation), with consensus EPS of -0.60. In the last 8 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Dec 31, 2022 → Aug 10, 2026
Dec 31, 2022Range: -1.46 ~ -0.08Aug 10, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 10, 2026 | -- | -0.51 | Below forecast↓-0.55 | -- | -- |
| May 13, 2026 | -- | -0.55 | Above forecast↑-0.48 | -- | -- |
| Mar 12, 2026 | -- | -0.61 | Above forecast↑-0.45 | -- | -- |
| Nov 12, 2025 | -- | -0.56 | Above forecast↑-0.55 | -- | -- |
| Aug 11, 2025 | -- | -0.48 | Above forecast↑-0.46 | -- | -- |
| May 14, 2025 | -- | -0.57 | Above forecast↑-0.40 | -- | -- |
| Mar 6, 2025 | -- | -0.68 | Above forecast↑-0.49 | -- | -- |
| Nov 13, 2024 | -- | -0.40 | Below forecast↓-1.46 | -- | -- |
| Aug 1, 2024 | -- | -- | -0.76 | -- | -- |
| Apr 25, 2024 | -- | -- | -0.14 | -- | -- |
| Dec 31, 2023 | -- | -- | -0.08 | -- | -- |
| Sep 30, 2023 | -- | -- | -0.10 | -- | -- |
| Jun 30, 2023 | -- | -- | -0.10 | -- | -- |
| Mar 31, 2023 | -- | -- | -0.09 | -- | -- |
| Dec 31, 2022 | -- | -- | -0.98 | -- | -- |
Original Filings (SEC)
Quarterly10-Q · 2026-08-10 ↗
Earnings Release8-K · 2026-08-10 ↗
Quarterly10-Q · 2026-05-13 ↗
Annual10-K · 2026-03-12 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
